Kuo C L, Chi C W, Liu T Y. The anti-inflammatory potential of berberine in vitro and in vivo [J]. Cancer Lett, 2004,23 ( 2 ) : 127.
[9]
Hsiang C Y, Wu S L, Cheng S E, et al. Acetaldehyde-induced interleukin-1 beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells[J]. J Biomed Sci, 2005,12(5) :791.
[10]
Yang J, Wang H D, Lu D X, et al. Effects of neutral sulfate berberine on LPS-induced cardiomyocyte TNF-alpha secretion, abnormal calcium cycling, and cardiac dysfunction in rats [J]. Acta Pharmacol Sin, 2006,27(2) :173.
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins[J]. Nat Med, 2004,10(12) :1344.
Brusq J M, Amcellin N, Grondin P, et al. Inhibition of lipid synthesis through activation of AMP kinase : an additional mechanism for the hypolipidemic effects of berberine[ J]. J Lipid Res, 2006,47(6) :1281.
[15]
Heieh Y S, Kuo W H, Lin T W, et al. Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells [ J ]. J Agric Food Chem, 2007,55(25) :10435.
[16]
Delcker M D. Influence of vascular risk factors for atherosclerotic carotid plaque wogression[J]. Stroke, 1995,26:2016.
Yin J, Gao Z, Liu D, et al. Berberine improves glucose metabolism through induction of glycolysis[J]. Am J Physiol Endocrinol Metab, 2008,294 ( 1 ) : 148.
[23]
Leng S H, Lu F E, Xu L J. Therapeutic efects of berberine in impaired glucose tolerance rats and its influence on insulin secretion[J]. Acta Pharmacol Sin, 2004,25(4) :496.
[24]
Yin J, tlu R, Chen M, et al. Effects of berberine on glucose metabolism in vitro[J]. Metabolism, 2002,51 ( 11 ) : 1439.
[25]
高从容 张家庆.黄连素增加胰岛素抵抗大鼠模型胰岛素敏感性的实验研究[J].中国中西医结合杂志,:.
[26]
Ko B S, Choi S B, Park S K, et al. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma [J]. Biol Pharm Bull, 2005,28(8) :1431.
[27]
Turner N, Li J Y, Gosby A, et al. Berberine, and its more biologically available derivative dihydroberberine, inhibit mitochondrial respiratory complexI: A mechanism for the action of berberine to activate AMPK and improve insulin action [J]. Diabete, 2008,19 : [ Epub ahead of print].
[28]
Wang Z S, Lu F E, Chen G. Effect of berberine on insulin secretion and glucokinase activity of NIT-1 cells[J]. Yao Xue Xue Bao, 2007,42 (10) : 1045.
[29]
Gorenne I, Kavurma M, Scott S, et al. Vascular smooth muscle cell senescence in atherosclerosis[J]. Cardiovasc Res, 2006,72 (1) :9.
[30]
Tanabe H, Suzuki H, Mizukami H, et al. Double blockade of cell cycle progression by coptisine in vascular smooth muscle cells [J]. Biochem Pharmacol, 2005,70(8) :1176.
[31]
Lee S, Lim H J, Park H Y, et al. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model[J]. Atherosclerosis, 2006,186 ( 1 ) :29.
[32]
Liang K W, Ting C T, Yin S C, et al. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury [J]. Biochemical pharmacol, 2006,71 ( 6 ) : 806.
[33]
Huang C G, Chu Z L, Wei S J, et al. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells[J]. Thromb Res, 2002,106(4-5) :223.
[34]
Jin X L, Shao Y, Wang M J, et al. Tetrahydroprotoberberines inhibit lipid peroxidation and scavenge hydroxyl free radicals [J]. Acta pharmacol Sin, 2000,21 (5) :447.
